{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:10:33Z","timestamp":1790644233244,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1159648"],"award-info":[{"award-number":["GNT1159648"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["206194\/Z\/17\/Z"],"award-info":[{"award-number":["206194\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI132359"],"award-info":[{"award-number":["R01 AI132359"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Diverse compounds target the\n                    <jats:italic>Plasmodium falciparum<\/jats:italic>\n                    Na\n                    <jats:sup>+<\/jats:sup>\n                    pump PfATP4, with cipargamin and (+)-SJ733 the most clinically-advanced. In a recent clinical trial for cipargamin, recrudescent parasites emerged, with most having a G358S mutation in PfATP4. Here, we show that PfATP4\n                    <jats:sup>G358S<\/jats:sup>\n                    parasites can withstand micromolar concentrations of cipargamin and (+)-SJ733, while remaining susceptible to antimalarials that do not target PfATP4. The G358S mutation in PfATP4, and the equivalent mutation in\n                    <jats:italic>Toxoplasma gondii<\/jats:italic>\n                    ATP4, decrease the sensitivity of ATP4 to inhibition by cipargamin and (+)-SJ733, thereby protecting parasites from disruption of Na\n                    <jats:sup>+<\/jats:sup>\n                    regulation. The G358S mutation reduces the affinity of PfATP4 for Na\n                    <jats:sup>+<\/jats:sup>\n                    and is associated with an increase in the parasite\u2019s resting cytosolic [Na\n                    <jats:sup>+<\/jats:sup>\n                    ]. However, no defect in parasite growth or transmissibility is observed. Our findings suggest that PfATP4 inhibitors in clinical development should be tested against PfATP4\n                    <jats:sup>G358S<\/jats:sup>\n                    parasites, and that their combination with unrelated antimalarials may mitigate against resistance development.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-33403-9","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T08:04:48Z","timestamp":1664525088000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["A G358S mutation in the Plasmodium falciparum Na+ pump PfATP4 confers clinically-relevant resistance to cipargamin"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7297-8660","authenticated-orcid":false,"given":"Deyun","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin V.","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E. O.","family":"Rosling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Thathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3914-3116","authenticated-orcid":false,"given":"John D.","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1561-0074","authenticated-orcid":false,"given":"Jocelyn Sietsma","family":"Penington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Tong Vincent","family":"Aw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Yi Han","family":"Aw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7699-8837","authenticated-orcid":false,"given":"Guoyue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9848-0142","authenticated-orcid":false,"given":"Abhai K.","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina F.","family":"Gnadig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2923-6060","authenticated-orcid":false,"given":"Tomas","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate J.","family":"Fairhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9519-487X","authenticated-orcid":false,"given":"Barbara H.","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Murithi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krittikorn","family":"K\u00fcmpornsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heath","family":"Hasemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelaide S. M.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6763-2366","authenticated-orcid":false,"given":"Melanie C.","family":"Ridgway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther K.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Straimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1102-8506","authenticated-orcid":false,"given":"Anthony T.","family":"Papenfuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4973-0915","authenticated-orcid":false,"given":"Marcus C. S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6324-442X","authenticated-orcid":false,"given":"Ben","family":"Corry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2954-7547","authenticated-orcid":false,"given":"Photini","family":"Sinnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6753-8938","authenticated-orcid":false,"given":"David A.","family":"Fidock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2455-9821","authenticated-orcid":false,"given":"Giel G.","family":"van Dooren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiaran","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0050-9101","authenticated-orcid":false,"given":"Adele M.","family":"Lehane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"33403_CR1","unstructured":"WHO. World Malaria Report (WHO, 2021)."},{"key":"33403_CR2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","volume":"385","author":"B Balikagala","year":"2021","unstructured":"Balikagala, B. et al. Evidence of artemisinin-resistant malaria in Africa. N. Engl. J. Med. 385, 1163\u20131171 (2021).","journal-title":"N. Engl. J. Med."},{"key":"33403_CR3","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/S1473-3099(19)30394-9","volume":"19","author":"D Menard","year":"2019","unstructured":"Menard, D. & Fidock, D. A. Accelerated evolution and spread of multidrug-resistant Plasmodium falciparum takes down the latest first-line antimalarial drug in southeast Asia. Lancet Infect. Dis. 19, 916\u2013917 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"33403_CR4","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","volume":"19","author":"RW van der Pluijm","year":"2019","unstructured":"van der Pluijm, R. W. et al. Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study. Lancet Infect. Dis. 19, 952\u2013961 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"33403_CR5","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S1473-3099(19)30392-5","volume":"19","author":"WL Hamilton","year":"2019","unstructured":"Hamilton, W. L. et al. Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study. Lancet Infect. Dis. 19, 943\u2013951 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"33403_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nature09107","volume":"465","author":"FJ Gamo","year":"2010","unstructured":"Gamo, F. J. et al. Thousands of chemical starting points for antimalarial lead identification. Nature 465, 305\u2013310 (2010).","journal-title":"Nature"},{"key":"33403_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature09099","volume":"465","author":"WA Guiguemde","year":"2010","unstructured":"Guiguemde, W. A. et al. Chemical genetics of Plasmodium falciparum. Nature 465, 311\u2013315 (2010).","journal-title":"Nature"},{"key":"33403_CR8","doi-asserted-by":"publisher","first-page":"9059","DOI":"10.1073\/pnas.0802982105","volume":"105","author":"D Plouffe","year":"2008","unstructured":"Plouffe, D. et al. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. Proc. Natl Acad. Sci. USA 105, 9059\u20139064 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"33403_CR9","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1126\/science.1193225","volume":"329","author":"M Rottmann","year":"2010","unstructured":"Rottmann, M. et al. Spiroindolones, a potent compound class for the treatment of malaria. Science 329, 1175\u20131180 (2010).","journal-title":"Science"},{"key":"33403_CR10","doi-asserted-by":"publisher","first-page":"10782","DOI":"10.1074\/jbc.M010554200","volume":"276","author":"S Krishna","year":"2001","unstructured":"Krishna, S. et al. Expression and functional characterization of a Plasmodium falciparum Ca2+-ATPase (PfATP4) belonging to a subclass unique to apicomplexan organisms. J. Biol. Chem. 276, 10782\u201310787 (2001).","journal-title":"J. Biol. Chem."},{"key":"33403_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.chom.2012.12.006","volume":"13","author":"NJ Spillman","year":"2013","unstructured":"Spillman, N. J. et al. Na+ regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials. Cell Host Microbe 13, 227\u2013237 (2013).","journal-title":"Cell Host Microbe"},{"key":"33403_CR12","doi-asserted-by":"publisher","first-page":"e00087","DOI":"10.1128\/AAC.00087-18","volume":"62","author":"ASM Dennis","year":"2018","unstructured":"Dennis, A. S. M., Lehane, A. M., Ridgway, M. C., Holleran, J. P. & Kirk, K. Cell swelling induced by the antimalarial KAE609 (cipargamin) and other PfATP4-associated antimalarials. Antimicrob. Agents Chemother. 62, e00087\u201318 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"key":"33403_CR13","doi-asserted-by":"publisher","first-page":"e1005647","DOI":"10.1371\/journal.ppat.1005647","volume":"12","author":"S Das","year":"2016","unstructured":"Das, S. et al. Na+ influx induced by new antimalarials causes rapid alterations in the cholesterol content and morphology of Plasmodium falciparum. PLoS Pathog. 12, e1005647 (2016).","journal-title":"PLoS Pathog."},{"key":"33403_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/infdis\/jiv358","volume":"213","author":"R Zhang","year":"2016","unstructured":"Zhang, R. et al. A basis for rapid clearance of circulating ring-stage malaria parasites by the spiroindolone KAE609. J. Infect. Dis. 213, 100\u2013104 (2016).","journal-title":"J. Infect. Dis."},{"key":"33403_CR15","doi-asserted-by":"publisher","first-page":"13327","DOI":"10.1074\/jbc.RA118.003640","volume":"293","author":"JEO Rosling","year":"2018","unstructured":"Rosling, J. E. O., Ridgway, M. C., Summers, R. L., Kirk, K. & Lehane, A. M. Biochemical characterization and chemical inhibition of PfATP4-associated Na+-ATPase activity in Plasmodium falciparum membranes. J. Biol. Chem. 293, 13327\u201313337 (2018).","journal-title":"J. Biol. Chem."},{"key":"33403_CR16","doi-asserted-by":"publisher","first-page":"C1576","DOI":"10.1152\/ajpcell.2001.280.6.C1576","volume":"280","author":"HM Staines","year":"2001","unstructured":"Staines, H. M., Ellory, J. C. & Kirk, K. Perturbation of the pump-leak balance for Na+ and K+ in malaria-infected erythrocytes. Am. J. Physiol. Cell Physiol. 280, C1576\u2013C1587 (2001).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"33403_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10727","volume":"7","author":"SM Ganesan","year":"2016","unstructured":"Ganesan, S. M., Falla, A., Goldfless, S. J., Nasamu, A. S. & Niles, J. C. Synthetic RNA-protein modules integrated with native translation mechanisms to control gene expression in malaria parasites. Nat. Commun. 7, 10727 (2016).","journal-title":"Nat. Commun."},{"key":"33403_CR18","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1074\/jbc.RA118.006706","volume":"294","author":"AM Lehane","year":"2019","unstructured":"Lehane, A. M. et al. Characterization of the ATP4 ion pump in Toxoplasma gondii. J. Biol. Chem. 294, 5720\u20135734 (2019).","journal-title":"J. Biol. Chem."},{"key":"33403_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26819-1","volume":"8","author":"ASM Dennis","year":"2018","unstructured":"Dennis, A. S. M., Rosling, J. E. O., Lehane, A. M. & Kirk, K. Diverse antimalarials from whole-cell phenotypic screens disrupt malaria parasite ion and volume homeostasis. Sci. Rep. 8, 8795 (2018).","journal-title":"Sci. Rep."},{"key":"33403_CR20","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1021\/cb500616x","volume":"10","author":"EL Flannery","year":"2015","unstructured":"Flannery, E. L. et al. Mutations in the P-type cation-transporter ATPase 4, PfATP4, mediate resistance to both aminopyrazole and spiroindolone antimalarials. ACS Chem. Biol. 10, 413\u2013420 (2015).","journal-title":"ACS Chem. Biol."},{"key":"33403_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46500-5","volume":"9","author":"PR Gilson","year":"2019","unstructured":"Gilson, P. R. et al. A 4-cyano-3-methylisoquinoline inhibitor of Plasmodium falciparum growth targets the sodium efflux pump PfATP4. Sci. Rep. 9, 10292 (2019).","journal-title":"Sci. Rep."},{"key":"33403_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1021\/acsinfecdis.6b00078","volume":"3","author":"SN Hewitt","year":"2017","unstructured":"Hewitt, S. N. et al. Biochemical and structural characterization of selective allosteric inhibitors of the Plasmodium falciparum drug target, prolyl-tRNA-synthetase. ACS Infect. Dis. 3, 34\u201344 (2017).","journal-title":"ACS Infect. Dis."},{"key":"33403_CR23","doi-asserted-by":"publisher","first-page":"E5455","DOI":"10.1073\/pnas.1414221111","volume":"111","author":"MB Jimenez-Diaz","year":"2014","unstructured":"Jimenez-Diaz, M. B. et al. (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium. Proc. Natl Acad. Sci. USA 111, E5455\u2013E5462 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"33403_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/mmi.12765","volume":"94","author":"AM Lehane","year":"2014","unstructured":"Lehane, A. M., Ridgway, M. C., Baker, E. & Kirk, K. Diverse chemotypes disrupt ion homeostasis in the malaria parasite. Mol. Microbiol. 94, 327\u2013339 (2014).","journal-title":"Mol. Microbiol"},{"key":"33403_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6521","volume":"5","author":"AB Vaidya","year":"2014","unstructured":"Vaidya, A. B. et al. Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum. Nat. Commun. 5, 5521 (2014).","journal-title":"Nat. Commun."},{"key":"33403_CR26","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/S1473-3099(19)30611-5","volume":"20","author":"AH Gaur","year":"2020","unstructured":"Gaur, A. H. et al. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a\/b trial. Lancet Infect. Dis. 20, 964\u2013975 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"33403_CR27","doi-asserted-by":"publisher","first-page":"101765","DOI":"10.1016\/j.tmaid.2020.101765","volume":"36","author":"SA Bouwman","year":"2020","unstructured":"Bouwman, S. A. et al. The early preclinical and clinical development of cipargamin (KAE609), a novel antimalarial compound. Travel Med. Infect. Dis. 36, 101765 (2020).","journal-title":"Travel Med. Infect. Dis."},{"key":"33403_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa1315860","volume":"371","author":"NJ White","year":"2014","unstructured":"White, N. J. et al. Spiroindolone KAE609 for falciparum and vivax malaria. N. Engl. J. Med. 371, 403\u2013410 (2014).","journal-title":"N. Engl. J. Med."},{"key":"33403_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16671-0","volume":"7","author":"KJ Dechering","year":"2017","unstructured":"Dechering, K. J. et al. Modelling mosquito infection at natural parasite densities identifies drugs targeting EF2, PI4K or ATP4 as key candidates for interrupting malaria transmission. Sci. Rep. 7, 17680 (2017).","journal-title":"Sci. Rep."},{"key":"33403_CR30","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1128\/AAC.03942-14","volume":"59","author":"LM Upton","year":"2015","unstructured":"Upton, L. M. et al. Lead clinical and preclinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations. Antimicrob. Agents Chemother. 59, 490\u2013497 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"33403_CR31","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1128\/AAC.06377-11","volume":"56","author":"JC van Pelt-Koops","year":"2012","unstructured":"van Pelt-Koops, J. C. et al. The spiroindolone drug candidate NITD609 potently inhibits gametocytogenesis and blocks Plasmodium falciparum transmission to anopheles mosquito vector. Antimicrob. Agents Chemother. 56, 3544\u20133548 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"33403_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-11-292","volume":"11","author":"XC Ding","year":"2012","unstructured":"Ding, X. C., Ubben, D. & Wells, T. N. A framework for assessing the risk of resistance for anti-malarials in development. Malar. J. 11, 292 (2012).","journal-title":"Malar. J."},{"key":"33403_CR33","doi-asserted-by":"publisher","first-page":"9389","DOI":"10.1073\/pnas.94.17.9389","volume":"94","author":"PK Rathod","year":"1997","unstructured":"Rathod, P. K., McErlean, T. & Lee, P. C. Variations in frequencies of drug resistance in Plasmodium falciparum. Proc. Natl Acad. Sci. USA 94, 9389\u20139393 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"33403_CR34","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1021\/acs.jmedchem.1c01995","volume":"65","author":"BR Taft","year":"2022","unstructured":"Taft, B. R. et al. Discovery and preclinical pharmacology of INE963, a potent and fast-acting blood-stage antimalarial with a high barrier to resistance and potential for single-dose cures in uncomplicated malaria. J. Med. Chem. 65, 3798\u20133813 (2022).","journal-title":"J. Med. Chem."},{"key":"33403_CR35","doi-asserted-by":"publisher","first-page":"e0154166","DOI":"10.1371\/journal.pone.0154166","volume":"11","author":"AH Lee","year":"2016","unstructured":"Lee, A. H. & Fidock, D. A. Evidence of a mild mutator phenotype in Cambodian Plasmodium falciparum malaria parasites. PLoS ONE 11, e0154166 (2016).","journal-title":"PLoS ONE"},{"key":"33403_CR36","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1021\/acsinfecdis.7b00276","volume":"4","author":"MR Luth","year":"2018","unstructured":"Luth, M. R., Gupta, P., Ottilie, S. & Winzeler, E. A. Using in vitro evolution and whole genome analysis to discover next generation targets for antimalarial drug discovery. ACS Infect. Dis. 4, 301\u2013314 (2018).","journal-title":"ACS Infect. Dis."},{"key":"33403_CR37","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1124\/dmd.115.069187","volume":"44","author":"SE Huskey","year":"2016","unstructured":"Huskey, S. E. et al. KAE609 (Cipargamin), a new spiroindolone agent for the treatment of malaria: evaluation of the absorption, distribution, metabolism, and excretion of a single oral 300-mg dose of [14C]KAE609 in healthy male subjects. Drug Metab. Dispos. 44, 672\u2013682 (2016).","journal-title":"Drug Metab. Dispos."},{"key":"33403_CR38","doi-asserted-by":"publisher","first-page":"6209","DOI":"10.1128\/AAC.03393-14","volume":"58","author":"FJ Leong","year":"2014","unstructured":"Leong, F. J. et al. A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel antimalarial Spiroindolone KAE609 (Cipargamin) to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers. Antimicrob. Agents Chemother. 58, 6209\u20136214 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"33403_CR39","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1128\/AAC.00340-15","volume":"59","author":"DS Stein","year":"2015","unstructured":"Stein, D. S. et al. Open-label, single-dose, parallel-group study in healthy volunteers to determine the drug-drug interaction potential between KAE609 (cipargamin) and piperaquine. Antimicrob. Agents Chemother. 59, 3493\u20133500 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"33403_CR40","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/cid\/ciab716","volume":"74","author":"EK Schmitt","year":"2021","unstructured":"Schmitt, E. K. et al. Efficacy of cipargamin (KAE609) in a randomized, Phase II dose-escalation study in adults in sub-Saharan Africa with uncomplicated Plasmodium falciparum malaria. Clin. Infect. Dis. 74, 1831\u20131839 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"33403_CR41","doi-asserted-by":"publisher","unstructured":"Kumpornsin, K. et al. Generation of a mutator parasite to drive resistome discovery in Plasmodium falciparum. Preprint at https:\/\/doi.org\/10.1101\/2022.08.23.504974 (2022).","DOI":"10.1101\/2022.08.23.504974"},{"key":"33403_CR42","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1128\/AAC.02225-13","volume":"58","author":"Y Zhou","year":"2014","unstructured":"Zhou, Y. et al. Spiroindolone that inhibits PfATPase4 is a potent, cidal inhibitor of Toxoplasma gondii tachyzoites in vitro and in vivo. Antimicrob. Agents Chemother. 58, 1789\u20131792 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"33403_CR43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"33403_CR44","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","volume":"19","author":"M Mirdita","year":"2022","unstructured":"Mirdita, M. et al. ColabFold: making protein folding accessible to all. Nat. Methods 19, 679\u2013682 (2022).","journal-title":"Nat. Methods"},{"key":"33403_CR45","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"33403_CR46","doi-asserted-by":"publisher","first-page":"13513","DOI":"10.1074\/jbc.C900031200","volume":"284","author":"M Laursen","year":"2009","unstructured":"Laursen, M. et al. Cyclopiazonic acid is complexed to a divalent metal ion when bound to the sarcoplasmic reticulum Ca2+-ATPase. J. Biol. Chem. 284, 13513\u201313518 (2009).","journal-title":"J. Biol. Chem."},{"key":"33403_CR47","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.chembiol.2020.04.002","volume":"27","author":"M Marchesini","year":"2020","unstructured":"Marchesini, M. et al. Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia. Cell Chem. Biol. 27, 678\u2013697.e13 (2020).","journal-title":"Cell Chem. Biol."},{"key":"33403_CR48","doi-asserted-by":"publisher","first-page":"e0178163","DOI":"10.1371\/journal.pone.0178163","volume":"12","author":"ED Crawford","year":"2017","unstructured":"Crawford, E. D. et al. Plasmid-free CRISPR\/Cas9 genome editing in Plasmodium falciparum confirms mutations conferring resistance to the dihydroisoquinolone clinical candidate SJ733. PLoS ONE 12, e0178163 (2017).","journal-title":"PLoS ONE"},{"key":"33403_CR49","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1086\/507115","volume":"194","author":"AB Sidhu","year":"2006","unstructured":"Sidhu, A. B. et al. Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J. Infect. Dis. 194, 528\u2013535 (2006).","journal-title":"J. Infect. Dis."},{"key":"33403_CR50","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"W Trager","year":"1976","unstructured":"Trager, W. & Jensen, J. B. Human malaria parasites in continuous culture. Science 193, 673\u2013675 (1976).","journal-title":"Science"},{"key":"33403_CR51","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2307\/3280287","volume":"65","author":"C Lambros","year":"1979","unstructured":"Lambros, C. & Vanderberg, J. P. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65, 418\u2013420 (1979).","journal-title":"J. Parasitol."},{"key":"33403_CR52","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.molbiopara.2009.09.005","volume":"169","author":"RJ Allen","year":"2010","unstructured":"Allen, R. J. & Kirk, K. Plasmodium falciparum culture: the benefits of shaking. Mol. Biochem. Parasitol. 169, 63\u201365 (2010).","journal-title":"Mol. Biochem. Parasitol."},{"key":"33403_CR53","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-1-60761-652-8_6","volume":"634","author":"SH Adjalley","year":"2010","unstructured":"Adjalley, S. H., Lee, M. C. & Fidock, D. A. A method for rapid genetic integration into Plasmodium falciparum utilizing mycobacteriophage Bxb1 integrase. Methods Mol. Biol. 634, 87\u2013100 (2010).","journal-title":"Methods Mol. Biol."},{"key":"33403_CR54","doi-asserted-by":"publisher","first-page":"eabg6013","DOI":"10.1126\/scitranslmed.abg6013","volume":"13","author":"JM Murithi","year":"2021","unstructured":"Murithi, J. M. et al. The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance. Sci. Transl. Med. 13, eabg6013 (2021).","journal-title":"Sci. Transl. Med."},{"key":"33403_CR55","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1124\/mol.54.6.1140","volume":"54","author":"DA Fidock","year":"1998","unstructured":"Fidock, D. A., Nomura, T. & Wellems, T. E. Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase. Mol. Pharm. 54, 1140\u20131147 (1998).","journal-title":"Mol. Pharm."},{"key":"33403_CR56","doi-asserted-by":"publisher","first-page":"10190","DOI":"10.1074\/jbc.273.17.10190","volume":"273","author":"KJ Saliba","year":"1998","unstructured":"Saliba, K. J., Horner, H. A. & Kirk, K. Transport and metabolism of the essential vitamin pantothenic acid in human erythrocytes infected with the malaria parasite Plasmodium falciparum. J. Biol. Chem. 273, 10190\u201310195 (1998).","journal-title":"J. Biol. Chem."},{"key":"33403_CR57","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.chom.2020.02.005","volume":"27","author":"P Favuzza","year":"2020","unstructured":"Favuzza, P. et al. Dual plasmepsin-targeting antimalarial agents disrupt multiple stages of the malaria parasite life cycle. Cell Host Microbe 27, 642\u2013658.e12 (2020).","journal-title":"Cell Host Microbe"},{"key":"33403_CR58","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"33403_CR59","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1093\/nar\/gkr599","volume":"39","author":"Z Wei","year":"2011","unstructured":"Wei, Z., Wang, W., Hu, P., Lyon, G. J. & Hakonarson, H. SNVer: a statistical tool for variant calling in analysis of pooled or individual next-generation sequencing data. Nucleic Acids Res. 39, e132 (2011).","journal-title":"Nucleic Acids Res."},{"key":"33403_CR60","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568\u2013576 (2012).","journal-title":"Genome Res."},{"key":"33403_CR61","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1101\/gr.175141.114","volume":"24","author":"I Scheinin","year":"2014","unstructured":"Scheinin, I. et al. DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly. Genome Res. 24, 2022\u20132032 (2014).","journal-title":"Genome Res."},{"key":"33403_CR62","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1101\/gr.222109.117","volume":"27","author":"DL Cameron","year":"2017","unstructured":"Cameron, D. L. et al. GRIDSS: sensitive and specific genomic rearrangement detection using positional de Bruijn graph assembly. Genome Res. 27, 2050\u20132060 (2017).","journal-title":"Genome Res."},{"key":"33403_CR63","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 6, 80\u201392 (2012).","journal-title":"Fly (Austin)"},{"key":"33403_CR64","doi-asserted-by":"publisher","first-page":"E1128","DOI":"10.1073\/pnas.1110574108","volume":"108","author":"R Xi","year":"2011","unstructured":"Xi, R. et al. Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion. Proc. Natl Acad. Sci. USA 108, E1128\u2013E1136 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"33403_CR65","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.chembiol.2021.06.006","volume":"29","author":"JM Murithi","year":"2021","unstructured":"Murithi, J. M. et al. The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance. Cell Chem. Biol. 29, 824\u2013839 (2021).","journal-title":"Cell Chem. Biol."},{"key":"33403_CR66","doi-asserted-by":"publisher","first-page":"e54974","DOI":"10.1371\/journal.pone.0054974","volume":"8","author":"C Spry","year":"2013","unstructured":"Spry, C. et al. Pantothenamides are potent, on-target inhibitors of Plasmodium falciparum growth when serum pantetheinase is inactivated. PLoS ONE 8, e54974 (2013).","journal-title":"PLoS ONE"},{"key":"33403_CR67","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","volume":"48","author":"M Smilkstein","year":"2004","unstructured":"Smilkstein, M., Sriwilaijaroen, N., Kelly, J. X., Wilairat, P. & Riscoe, M. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob. Agents Chemother. 48, 1803\u20131806 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"33403_CR68","doi-asserted-by":"publisher","first-page":"e01114","DOI":"10.1128\/mBio.01114-14","volume":"5","author":"B Shen","year":"2014","unstructured":"Shen, B., Brown, K. M., Lee, T. D. & Sibley, L. D. Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR\/CAS9. mBio 5, e01114\u201314 (2014).","journal-title":"mBio"},{"key":"33403_CR69","doi-asserted-by":"publisher","first-page":"e1007577","DOI":"10.1371\/journal.ppat.1007577","volume":"15","author":"KER Parker","year":"2019","unstructured":"Parker, K. E. R. et al. The tyrosine transporter of Toxoplasma gondii is a member of the newly defined apicomplexan amino acid transporter (ApiAT) family. PLoS Pathog. 15, e1007577 (2019).","journal-title":"PLoS Pathog."},{"key":"33403_CR70","doi-asserted-by":"publisher","first-page":"19335","DOI":"10.1074\/jbc.M116.725069","volume":"291","author":"GG van Dooren","year":"2016","unstructured":"van Dooren, G. G., Yeoh, L. M., Striepen, B. & McFadden, G. I. The import of proteins into the mitochondrion of Toxoplasma gondii. J. Biol. Chem. 291, 19335\u201319350 (2016).","journal-title":"J. Biol. Chem."},{"key":"33403_CR71","doi-asserted-by":"publisher","first-page":"13574","DOI":"10.1073\/pnas.0803862105","volume":"105","author":"GG van Dooren","year":"2008","unstructured":"van Dooren, G. G., Tomova, C., Agrawal, S., Humbel, B. M. & Striepen, B. Toxoplasma gondii Tic20 is essential for apicoplast protein import. Proc. Natl Acad. Sci. USA 105, 13574\u201313579 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"33403_CR72","doi-asserted-by":"crossref","unstructured":"Ernst, O. & Zor, T. Linearization of the bradford protein assay. J. Vis. Exp. 38, e1918 (2010).","DOI":"10.3791\/1918"},{"key":"33403_CR73","doi-asserted-by":"publisher","DOI":"10.3791\/61426","author":"AK Tripathi","year":"2020","unstructured":"Tripathi, A. K., Mlambo, G., Kanatani, S., Sinnis, P. & Dimopoulos, G. Plasmodium falciparum gametocyte culture and mosquito infection through artificial membrane feeding. J. Vis. Exp. https:\/\/doi.org\/10.3791\/61426 (2020).","journal-title":"J. Vis. Exp."},{"key":"33403_CR74","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nmeth.1818","volume":"9","author":"M Remmert","year":"2011","unstructured":"Remmert, M., Biegert, A., Hauser, A. & Soding, J. HHblits: lightning-fast iterative protein sequence searching by HMM-HMM alignment. Nat. Methods 9, 173\u2013175 (2011).","journal-title":"Nat. Methods"},{"key":"33403_CR75","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/nbt.3988","volume":"35","author":"M Steinegger","year":"2017","unstructured":"Steinegger, M. & Soding, J. MMseqs2 enables sensitive protein sequence searching for the analysis of massive data sets. Nat. Biotechnol. 35, 1026\u20131028 (2017).","journal-title":"Nat. Biotechnol."},{"key":"33403_CR76","doi-asserted-by":"publisher","unstructured":"Lindahl, Abraham, Hess & van der Spoel. GROMACS 2021 Manual (Version 2021). Zenodo https:\/\/doi.org\/10.5281\/zenodo.4457591 (2021).","DOI":"10.5281\/zenodo.4457591"},{"key":"33403_CR77","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/prot.21123","volume":"65","author":"V Hornak","year":"2006","unstructured":"Hornak, V. et al. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins 65, 712\u2013725 (2006).","journal-title":"Proteins"},{"key":"33403_CR78","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/bs.apcsb.2014.06.002","volume":"96","author":"S Jo","year":"2014","unstructured":"Jo, S. et al. CHARMM-GUI PDB manipulator for advanced modeling and simulations of proteins containing nonstandard residues. Adv. Protein Chem. Struct. Biol. 96, 235\u2013265 (2014).","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"33403_CR79","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph 14, 33\u201338 (1996).","journal-title":"J. Mol. Graph"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33403-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33403-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33403-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T01:17:13Z","timestamp":1701134233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33403-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["33403"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-33403-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.01.11.475938","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"assertion":[{"value":"26 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.K.S. and J.S. are employees and shareholders of Novartis, which funded aspects of the work. The other authors have no competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5746"}}